A CROSS-SECTIONAL STUDY ON THE ASSOCIATION OF HYPOMAGNESEMIA WITH DIABETIC COMPLICATIONS
Main Article Content
Keywords
Neuropathy, retinopathy, HbA1c, hypertension, hypomagnesemia
Abstract
Background: Magnesium is considered an essential electrolyte for any living organism and is the fourth most abundant mineral in the human body. It serves as a cofactor for over 600 vital enzymatic reactions in the human body and an activator for an additional 200. The decrease in the level of magnesium may result in a defective tyrosine-kinase activity, causing detremental effect on the insulin receptors resulting in an impairment of insulin action.
Objective: To study the association of hypomagnesemia with diabetic complications in type2 diabetics
Materials and method: The present cross-sectional study was conducted at the Department of medicine, Bolan medical college/ Bolan medical complex hospital Quetta from July 2023 to December 2023 for six months of duration after the provision of the certificate from the institutional interview board. A total of 100 diabetic admitted patients were randomly selected for the study ages from 30 to 70 years irrespective of their gender. Informed consent was obtained from each participant. Magnesium levels below1.6 mg/dl were used as the standard for hypomagnesemia. All the participants were assured that their confidentiality and privacy would be maintained. The data was collected from each participant. All the collected data through physical assessment were analyzed by using the latest SPSS 24.
Results: A total of 100 diabetic admitted patients were randomly selected for the study ages from 30 to 70 years irrespective of their gender. The mean age of the participants was 53.86 ±9.74 years. The mean HbA1c of the participants was 8.7 ± 2.32. 48 % of them had HbA1c less than 8 while 52 % had greater than 8 HbA1c. The mean HbA1c in the hypomagnesemia group was 10.8 ± 1.98 while in normomagnesemia was 8.9 ± 2.2. There were 58.97%-foot ulcers among Group 1 while in Group 2 was 31.14%. 38.46 % and 14.75 % had neuropathy in Groups 1 and 2 respectively. Nephropathy in Group 1 was 28.20 % and in Group 2 was 11.47 %. 69.23% of Group 1 had retinopathy and 37.70 % was in Group 2. Hypertension was 23.07 % in Group 1 and 37.70% in Group 2, moreover, 7.69 % and 8.19% had coronary diseases in Groups 1 and 2 accordingly.
Conclusion: The current study concluded that hypomagnesemia was found to have an association with diabetic complications like neuropathy, nephropathy, foot ulcers, and poor glycemic control as evidenced by HbA1c.
References
2. Nasri H. Consequences of hypomagnesemia in type 2 diabetes mellitus patients. Journal of Renal Injury Prevention. 2014;3(4):99.
3. De Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiological reviews. 2015.
4. Mahalle N, Garg MK, Kulkarni MV, Naik SS. Relation of magnesium with insulin resistance and inflammatory markers in subjects with known Coronary artery disease. Journal of Cardiovascular Disease Research. 2014;5(1):22.
5. Ramadass S, Basu S, Srinivasan AR. SERUM magnesium levels as an indicator of status of Diabetes Mellitus type 2. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2015 Jan 1;9(1):42-5.
6. Feng J, Wang H, Jing Z, Wang Y, Cheng Y, Wang W, Sun W. Role of magnesium in type 2 diabetes mellitus. Biological trace element research. 2020 Jul;196:74-85.
7. Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs Jr DR, He K. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes care. 2010 Dec 1;33(12):2604-10.
8. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clinical journal of the American Society of Nephrology. 2007 Mar 1;2(2):366-73.
9. Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH. Hypomagnesemia in type 2 diabetes: a vicious circle?. Diabetes. 2016 Jan 1;65(1):3-13.
10. 10: Pokharel DR, Khadka D, Sigdel M, Yadav NK, Kafle R, Sapkota RM, Jha SK. Association of serum magnesium level with poor glycemic control and renal functions in Nepalese patients with type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017 Nov 1;11:S417-23.
11. Waanders F, Dullaart RP, Vos MJ, Hendriks SH, van Goor H, Bilo HJ, van Dijk PR. Hypomagnesaemia and its determinants in a contemporary primary care cohort of persons with type 2 diabetes. Endocrine. 2020 Jan;67:80-6.
12. Lu J, Gu Y, Guo M, Chen P, Wang H, Yu X. Serum magnesium concentration is inversely associated with albuminuria and retinopathy among patients with diabetes. Journal of diabetes research. 2016 Jul 31;2016.
13. Arpaci D, Tocoglu AG, Ergenc H, Korkmaz S, Ucar A, Tamer A. Associations of serum Magnesium levels with diabetes mellitus and diabetic complications. Hippokratia. 2015 Apr;19(2):153.
14. Zhang Y, Li Q, Xin Y, Lv W, Ge C. Association between serum magnesium and common complications of diabetes mellitus. Technology and Health Care. 2018 Jan 1;26(S1):379-87.
15. Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian journal of endocrinology and metabolism. 2012 Nov;16(6):1000.
16. Hamarshih M, Hamshari S, Nazzal Z, Snobar F, Mletat R, Abu-Mazen O, Maraqa B. Hypomagnesemia and Poor Glycemic Control among Type 2 Diabetic Patients: A Cross-Sectional Study. Indian Journal of Endocrinology and Metabolism. 2022 Nov 1;26(6):575-80.
17. Joy SS, George TP, Siddiqui K. Low magnesium level as an indicator of poor glycemic control in type 2 diabetic patients with complications. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019 Mar 1;13(2):1303-7.
18. Hyassat D, Al Sitri E, Batieha A, Mohammed EK, Ajlouni K. Prevalence of hypomagnesaemia among obese type 2 diabetic patients attending the National Center for Diabetes, Endocrinology and Genetics (NCDEG). International journal of endocrinology and metabolism. 2014 Jul;12(3).